© 1995 American Heart Association, Inc.
Articles |
Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness
From the Department of Comparative Medicine and Comparative Medicine Clinical Research Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC.
Correspondence to Michael R. Adams, DVM, Department of Comparative Medicine, Bowman Gray School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1040.
Abstract The factors responsible for the marked gender differences in risk of coronary heart disease and atherosclerosis severity remain largely undetermined. While some clinical and experimental evidence supports a protective effect of endogenous estrogen on the initiation and progression of atherosclerosis and incidence of coronary heart disease, much of the epidemiological data do not support this conclusion. The possibility that endogenous androgens may have adverse effects on atherosclerosis progression and coronary risk has received little attention. We investigated the effects of experimentally induced hyperandrogenism in female cynomolgus monkeys with diet-induced atherosclerosis. Animals were assigned randomly to one of four treatment groups: (1) untreated controls, (2) ovariectomized (sex hormone-deficient) controls, (3) treated with androstenedione and estrone (mild hyperandrogenism), or (4) treated with testosterone (male plasma androgen pattern). At necropsy, coronary atherosclerosis was approximately twice as extensive (P<.05) in testosterone-treated animals relative to untreated controls, while treatment with androstenedione and estrone had no effect on atherosclerosis extent. Coronary plaque size was positively correlated with lumen size in intact and ovariectomized controls; however, there was no evidence of a similar relation between animals in either androgen treatment group. The atherogenic effects of testosterone were independent of variations in plasma lipoprotein and nonlipoprotein risk variables. Although chronic hyperandrogenism had adverse effects on atherosclerosis progression, it reversed (P<.03) atherosclerosis-related impairment of endothelium-dependent vasodilator responses. We conclude that an experimentally induced male plasma androgen pattern results in exacerbation of diet-induced atherosclerosis and has potentially adverse effects on atherosclerosis-related arterial remodeling in female monkeys. The results indicate that testosterone may have a direct role in the increased rate of atherosclerosis progression and increased risk of coronary heart disease seen in men, relative to women, in most Western societies.
Key Words: atherosclerosis • coronary heart disease • cynomolgus monkeys • vasomotion • androgens
This article has been cited by other articles:
 |
|
 |
|
  Y. Ikeda, K.-i. Aihara, S. Yoshida, T. Sato, S. Yagi, T. Iwase, Y. Sumitomo, T. Ise, K. Ishikawa, H. Azuma, et al. Androgen-Androgen Receptor System Protects against Angiotensin II-Induced Vascular Remodeling Endocrinology, June 1, 2009; 150(6): 2857 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Romualdi, B. Costantini, L. Selvaggi, M. Giuliani, F. Cristello, F. Macri, A. Bompiani, A. Lanzone, and M. Guido Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective Hum. Reprod., September 1, 2008; 23(9): 2127 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Luque-Ramirez, C. Mendieta-Azcona, F. Alvarez-Blasco, and H. F. Escobar-Morreale Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome Hum. Reprod., December 1, 2007; 22(12): 3197 - 3203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Miller, B. M. K. Biller, A. Schaub, K. Pulaski-Liebert, G. Bradwin, N. Rifai, and A. Klibanski Effects of Testosterone Therapy on Cardiovascular Risk Markers in Androgen-Deficient Women with Hypopituitarism J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2474 - 2479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Gilliver, J. J. Ashworth, S. J. Mills, M. J. Hardman, and G. S. Ashcroft Androgens modulate the inflammatory response during acute wound healing J. Cell Sci., February 15, 2006; 119(4): 722 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lakhani, A. Leonard, A.M. Seifalian, and P. Hardiman Microvascular dysfunction in women with polycystic ovary syndrome Hum. Reprod., November 1, 2005; 20(11): 3219 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hashimura, K. Sudhir, J. Nigro, S. Ling, M. R. I. Williams, P. A. Komesaroff, and P. J. Little Androgens Stimulate Human Vascular Smooth Muscle Cell Proteoglycan Biosynthesis and Increase Lipoprotein Binding Endocrinology, April 1, 2005; 146(4): 2085 - 2090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cakir, O. Ozcan, H. Yaman, E. O. Akgul, C. Bilgi, M. K. Erbil, and Z. Yesilova Elevated Plasma Concentration of Asymmetric Dimethylarginine That Is Reduced by Single Dose Testosterone Administration in Idiopathic Hypogonadotropic Hypogonadism Patients J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1651 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Er, G. Michels, N. Gassanov, F. Rivero, and U. C. Hoppe Testosterone Induces Cytoprotection by Activating ATP-Sensitive K+ Channels in the Cardiac Mitochondrial Inner Membrane Circulation, November 9, 2004; 110(19): 3100 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Littleton-Kearney and P. D. Hurn Testosterone as a Modulator of Vascular Behavior Biol Res Nurs, April 1, 2004; 5(4): 276 - 285. [Abstract] [PDF]
|
|
|
|
|
|
A. K. Death, K. C. Y. McGrath, M. A. Sader, S. Nakhla, W. Jessup, D. J. Handelsman, and D. S. Celermajer Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression in Male Human Endothelial Cells via a Nuclear Factor-{kappa}B-Dependent Pathway Endocrinology, April 1, 2004; 145(4): 1889 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. F. Ba, Y. Yokoyama, B. Toth, L. W. Rue III, K. I. Bland, and I. H. Chaudry Gender differences in small intestinal endothelial function: inhibitory role of androgens Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G452 - G457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chatrath, K. L. Ronningen, S. R. Severson, P. LaBreche, M. Jayachandran, M. P. Bracamonte, and V. M. Miller Endothelium-dependent responses in coronary arteries are changed with puberty in male pigs Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1168 - H1176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Cavasin, S. S. Sankey, A.-L. Yu, S. Menon, and X.-P. Yang Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1560 - H1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zitzmann, M. Brune, and E. Nieschlag Vascular Reactivity in Hypogonadal Men Is Reduced by Androgen Substitution J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5030 - 5037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Hak, J. C. M. Witteman, F. H. de Jong, M. I. Geerlings, A. Hofman, and H. A. P. Pols Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3632 - 3639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ling, A. Dai, M. R. I. Williams, K. Myles, R. J. Dilley, P. A. Komesaroff, and K. Sudhir Testosterone (T) Enhances Apoptosis-Related Damage in Human Vascular Endothelial Cells Endocrinology, March 1, 2002; 143(3): 1119 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Diamanti-Kandarakis, G. Spina, C. Kouli, and I. Migdalis Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4666 - 4673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zitzmann, M. Brune, B. Kornmann, J. Gromoll, S. von Eckardstein, A. von Eckardstein, and E. Nieschlag The CAG Repeat Polymorphism in the AR Gene Affects High Density Lipoprotein Cholesterol and Arterial Vasoreactivity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4867 - 4873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Caplea, D. Seachrist, G. Dunphy, and D. Ely Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1793 - H1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Nathan, W. Shi, H. Dinh, T. K. Mukherjee, X. Wang, A. J. Lusis, and G. Chaudhuri Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase PNAS, March 1, 2001; (2001) 51003698. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Sader, K. A. Griffiths, R. J. McCredie, D. J. Handelsman, and D. S. Celermajer Androgenic anabolic steroids and arterial structure and function in male bodybuilders J. Am. Coll. Cardiol., January 1, 2001; 37(1): 224 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.J. Pugh, K.M. English, T.H. Jones, and K.S. Channer Testosterone: a natural tonic for the failing heart? QJM, October 1, 2000; 93(10): 689 - 694. [Full Text] [PDF]
|
|
|
|
 |
|
 G.M.C. Rosano Androgens and coronary artery disease. A sex-specific effect of sex hormones? Eur. Heart J., June 1, 2000; 21(11): 868 - 871. [PDF]
|
|
|
|
 |
|
 C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hayashi, T. Esaki, E. Muto, H. Kano, Y. Asai, N. K. Thakur, D. Sumi, M. Jayachandran, and A. Iguchi Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen : The Possible Role of Nitric Oxide Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 782 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Teoh, A. Quan, and R. Y.K Man Acute impairment of relaxation by low levels of testosterone in porcine coronary arteries Cardiovasc Res, March 1, 2000; 45(4): 1010 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. McCrohon, A. K. Death, S. Nakhla, W. Jessup, D. J. Handelsman, K. K. Stanley, and D. S. Celermajer Androgen Receptor Expression Is Greater in Macrophages From Male Than From Female Donors : A Sex Difference With Implications for Atherogenesis Circulation, January 25, 2000; 101(3): 224 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhu, B. Bonet, H. Gillenwater, and R. H. Knopp Opposing Effects of Estrogen and Progestins on LDL Oxidation and Vascular Wall Cytotoxicity: Implications for Atherogenesis Experimental Biology and Medicine, December 1, 1999; 222(3): 214 - 221. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Webb, J. G. McNeill, C. S. Hayward, D. de Zeigler, and P. Collins Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease Circulation, October 19, 1999; 100(16): 1690 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. McCrohon, W. Jessup, D. J. Handelsman, and D. S. Celermajer Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule-1 Circulation, May 4, 1999; 99(17): 2317 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCredie, J. A. McCrohon, L. Turner, K. A. Griffiths, D. J. Handelsman, and D. S. Celermajer Vascular reactivity is impaired in genetic females taking high-dose androgens J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1331 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Bagatell and W. J. Bremner V. The Effects of Aging and Testosterone on Lipids and Cardiovascular Risk J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3440 - 3441. [Full Text]
|
|
|
|
|
|
D. A. Barber and V. M. Miller Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2325 - H2332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Herman, J. T.C. Robinson, R. J. McCredie, M. R. Adams, M. J. Boyer, and D. S. Celermajer Androgen Deprivation Is Associated With Enhanced Endothelium-Dependent Dilatation in Adult Men Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2004 - 2009. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Roberts, M. M. Woo, and J. C. Rutledge Nitric Oxide Mediates LDL Uptake in the Artery Wall in Response to High Concentrations of 17ß-Estradiol Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2123 - 2131. [Abstract] [Full Text]
|
|
|
|
|
|
G. E. Croston, L. B. Milan, K. B. Marschke, M. Reichman, and M. R. Briggs Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes Endocrinology, September 1, 1997; 138(9): 3779 - 3786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Williams, J. D. Wagner, Z. Li, D. L. Golden, and M. R. Adams Tamoxifen Inhibits Arterial Accumulation of LDL Degradation Products and Progression of Coronary Artery Atherosclerosis in Monkeys Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 403 - 408. [Abstract] [Full Text]
|
|
|
|
|
|
L. Nathan, W. Shi, H. Dinh, T. K. Mukherjee, X. Wang, A. J. Lusis, and G. Chaudhuri Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase PNAS, March 13, 2001; 98(6): 3589 - 3593. [Abstract] [Full Text] [PDF]
|
|